WHO grants prequalification of Actemra/RoActemra for patients with severe or critical COVID-19
WHO’s prequalification adds to several mechanisms already in place to improve access to Actemra/RoActemra for people with COVID-19 in low- and middle-income countries Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra, as recommended in global treatment guidelines Twelfth Roche medicine or test to be... Read more
Bruker Reports Fourth Quarter and Fiscal Year 2021 Financial Results
Q4 2021 revenues $683.5M, up 8.9% year-over-year (yoy); organic revenue growth of 11.4% yoy Q4 2021 GAAP EPS $0.50; non-GAAP EPS $0.59, up $0.01 yoy FY 2021 revenues of $2.42B, up 21.7% yoy; organic revenue growth of 19.1% yoy FY 2021 GAAP EPS $1.81; non-GAAP EPS $2.10, up 55.6% yoy Solid organic revenue and non-GAAP... Read more
New two-year data for Roche’s Vabysmo and Susvimo reinforce potential to maintain vision with fewer treatments for people with two leading causes of vision loss
In the YOSEMITE and RHINE studies in diabetic macular edema, at least 60% of eligible Vabysmo patients could extend treatment to every four months at two years, compared to 50% at year one Almost 80% of eligible Vabysmo patients could extend treatment to every three months or longer in both studies In the Archway study... Read more
PerkinElmer to Present at Citi’s 2022 Virtual Healthcare Conference
WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 10, 2022– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at Citi’s 2022 Virtual Healthcare Conference on Thursday, February 24, 2022 at 8:45 a.m. ET. Prahlad Singh, president and chief executive officer of PerkinElmer, will provide an overview on... Read more
Bruker Corporation to Present at the 11th Annual SVB Leerink Global Healthcare Conference
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 11th Annual SVB Leerink Global Healthcare Conference, being held virtually. Frank Laukien, Chairman, President & CEO will present on behalf of the Company on Wednesday, February 16th, 2022 at 8:40 AM Eastern Standard Time. A live audio webcast of the presentation... Read more
Notice Concerning Forecast Revisions of Financial Results and Dividend (Dividend Increase)
Notice Concerning Forecast Revisions of Financial Results and Dividend (Dividend Increase) | IR News | News Release ＆ IR News | Investor Relations Read more
Consolidated Financial Statements for the Third Quarter Ended December 31, 2021 FY2022 (April 1, 2021-March 31, 2022) [UNAUDITED]
Consolidated Financial Statements for the Third Quarter Ended December 31, 2021 FY2022 (April 1, 2021-March 31, 2022) [UNAUDITED] | IR News | News Release ＆ IR News | Investor Relations Read more
PacBio to Present at Upcoming Investor Conferences
MENLO PARK, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) — PacBio announced today that its executives will be speaking virtually at the following investor conferences: 11th Annual SVB Leerink Global Healthcare Conference on February 16, 2022, at 3:00 pm Eastern Time (12:00 pm Pacific Time) Cowen 42nd Annual Health Care Conference on March 7, 2022, at... Read more